facebook pixel
Gondola Logo

Posts with or without credits tagged 'nvsq223'

  • 5 posts
  • 241 likes
  • 36 shares
  • 11 comments
X aka Twitter
@Novartis
Novartis is transforming into a pure-play Innovative Medicines business, with a focus on five core therapeutic areas that address high disease burden and have substantial growth potential. $NVS $NOVN #NVSQ223

 45

 9

 2

X aka Twitter
@Novartis
Board of Directors endorses the separation of Sandoz, by way of a 100% spin-off. Shareholder EGM planned for 15 September. $NVS $NOVN #NVSQ223

 107

 11

 3

X aka Twitter
@Novartis
Recent deals to bolster pipeline and strengthen technology platform. $NVS $NOVN #NVSQ223

 41

 6

 1

X aka Twitter
@Novartis
#NVSQ223 Novartis tweets on Q2 2023 results contain forward-looking statements. Such forward-looking statements are subject to significant known and unknown risks and uncertainties. Visit our website for more information t.co/CSl5Um0WV0.

 18

 3

 1

X aka Twitter
@Novartis
#Investors: Tune into Novartis Q2 and half year 2023 results on Tuesday, Jul 18. Hear the updates on our performance in five core therapeutic areas and progress in our strategy. $NVS #NOVN #NVSQ223

 30

 7

 4

Discover Posts with or without credits tagged 'nvsq223' on Gondola.